Scroll
To Top

Archives for: March 31st, 2017

Largest-Ever Study of SYNGAP1 (MRD5), Linked to Autism, was Launched

Written by Jennifer Huron on December 23, 2016

Research study is open to participants worldwide to advance understanding and treatments for rare disease causing non-syndromic intellectual disability ranging from mild to severe with attention deficits, impulsivity, and/or mood disorders. Seventy to eighty percent of children with SYNGAP1 also have some type of epilepsy and the SYNGAP1 gene has… Read More

A Message from Our President and CEO

Written by Christina Jensen on December 20, 2016

“When you are faced with a difficult health challenge, you need to be able to turn to a trusted source for support and advice – much like many people battling rare diseases have turned to NORD in the past 33 years.

NORD will keep fighting to eradicate the… Read More